Key statistics
On Tuesday, Cabaletta Bio Inc (CABA:NSQ) closed at 2.60, -29.16% below its 52-week high of 3.67, set on Oct 31, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 2.42 |
|---|---|
| High | 2.69 |
| Low | 2.42 |
| Bid | 2.55 |
| Offer | 2.59 |
| Previous close | 2.44 |
| Average volume | 2.58m |
|---|---|
| Shares outstanding | 96.27m |
| Free float | 94.75m |
| P/E (TTM) | -- |
| Market cap | 234.89m USD |
| EPS (TTM) | -2.51 USD |
Data delayed at least 15 minutes, as of Feb 10 2026 21:00 GMT.
More ▼
- Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
- Cabaletta Bio Announces 2026 Strategic Priorities
- Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
- Cabaletta Bio to Participate in Upcoming Investor Conferences in November and December
- Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025
- Cabaletta Bio Announces Appointment of Steve Gavel as Chief Commercial Officer and Award of Inducement Grant
- Cabaletta Bio Presents First Rese-cel Data with No Preconditioning Demonstrating Biologic Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress
- Cabaletta Bio to Participate in Upcoming Investor Conferences in September
- Cabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business Update
- Cabaletta Bio Announces Pricing of Public Offering of Securities
More ▼
